Owkin integrated its CE-marked MSIntuit CRC into Sectra's digital pathology platform.

MSI testing to find colorectal cancer patients eligible for immunotherapy consumes pathology resources. MSIntuit CRC now runs inside Sectra's platform so pre-screening fits existing workflows. The page states more than 96% sensitivity and that it rules out nearly half of patients from additional testing.

Owkin is a French AI company building biology models and the K Pro AI Scientist, working with pharma on drug positioning, trial design and pathology diagnostics.

This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.